The emerging fungal pathogen Candida auris resides on skin and spreads rapidly person-to-person in healthcare settings, a trait unique to this species. C. auris skin colonization places patients at risk for invasive infection, a diagnosis that accompanies a mortality rate as high as 60%. Further understanding of C. auris skin colonization is urgently needed for the development of innovative approaches to prevent spread of this drug- resistant and deadly pathogen. Our studies show that C. auris forms adherent biofilm structures in skin conditions in vitro and on porcine skin. Little is known about factors triggering this process or the fungal components involved in biofilm formation. The first objective of this application is to identify skin conditions and factors that promote C. auris biofilm growth and skin colonization. These data are essential to uncover fungal pathways involved in this process and to identify new approaches to prevent or reduce colonization. Furthermore, our compelling preliminary data show that skin niche biofilms exhibit a heightened capacity to produce a cohesive, extracellular matrix material. Our second objective is to characterize the components of this extracellular material. Knowledge of the matrix composition is critical to identify targets to disrupt the C. auris biofilms involved in skin colonization. These studies will provide the first insights into mechanisms of skin colonization for this emerging global public health threat. We anticipate the results of these studies will have broad implications for designing approaches to prevent skin colonization and transmission of this drug-resistant fungal pathogen.

Public Health Relevance

Candida auris has emerged as a global public health threat, causing invasive disease with high mortality. This yeast colonizes skin and rapidly spreads person-to-person in healthcare settings. The proposed studies will uncover the specific skin conditions that promote C. auris colonization and identify fungal cellular pathways involved in this process.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Exploratory/Developmental Grants (R21)
Project #
1R21AI159583-01
Application #
10194141
Study Section
Special Emphasis Panel (ZRG1)
Program Officer
Love, Dona
Project Start
2021-02-03
Project End
2023-01-31
Budget Start
2021-02-03
Budget End
2022-01-31
Support Year
1
Fiscal Year
2021
Total Cost
Indirect Cost
Name
University of Wisconsin Madison
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
161202122
City
Madison
State
WI
Country
United States
Zip Code
53715